Related Experiment Videos
Polypeptide growth factors: their potential value in the management of breast cancer patients
Cancer Treatment and Research
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study.
Breast cancer research and treatment·2017
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up.
Breast cancer research and treatment·2012
Systemic mirnas as potential biomarkers for malignancy.
International journal of cancer·2012
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone.
Molecular endocrinology (Baltimore, Md.)·2011
DNA repair signature is associated with anthracycline response in triple negative breast cancer patients.
Breast cancer research and treatment·2010
Clinical Trials and Translational Advances in Metabolic Targeting.
Cancer treatment and research·2026
Tools and Technologies for Studying Cancer Metabolism.
Cancer treatment and research·2026
Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.
Cancer treatment and research·2026
Biomarkers of Cancer Metabolism and Therapeutic Response.
Cancer treatment and research·2026
Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.
Cancer treatment and research·2026
Metabolic Reprogramming in Cancer Stem Cells.
Cancer treatment and research·2026